11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02102594 (ClinicalTrials.gov)	October 2014	25/3/2014	Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)	Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)	Myasthenia Gravis;Systemic Lupus Erythematosus;Rheumatoid Arthritis	Drug: Bortezomib	Charite University, Berlin, Germany	Prof. Dr. med. Falk Hiepe (Charité, Internal Medicine / Rheumathology);NeuroCure Clinical Research C ...	Terminated	18 Years	75 Years	All	11	Phase 2	Germany
2	EUCTR2013-005362-19-DE (EUCTR)	17/07/2014	18/12/2013	Therapy of antibody-mediated autoimmune diseases by Bortezomib (TAVAB)	Therapy of antibody-mediated autoimmune diseases by Bortezomib (TAVAB) - TAVAB	Myasthenia Gravis Systemic Lupus ErythematosusRheumatoid Arthritis;Therapeutic area: Diseases [C] - ...	Trade Name: Velcade ® INN or Proposed INN: BORTEZOMIB	Charité - Universitätsmedizin Berlin	NULL	Not Recruiting			Female: yes Male: yes	18	Phase 2	Germany

First Previous1Next Last